Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and suramin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with suramin in 4 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(suramin)
Trials
(suramin)
Recent Studies (post-2010) (suramin)
9,1561875523,02392431

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)suramin (IC50)
ATP-dependent 6-phosphofructokinaseTrypanosoma brucei brucei3
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)9.76
P2X purinoceptor 2Rattus norvegicus (Norway rat)4
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)1.7
DNA primaseMycobacterium tuberculosis CDC15518.2
RmtAAspergillus nidulans5.9
Reverse transcriptase/RNaseH Human immunodeficiency virus 19.4
NAD-dependent protein deacetylase sirtuin-2Homo sapiens (human)1.15
NAD-dependent protein deacetylase sirtuin-1Homo sapiens (human)1.5667
Protein arginine N-methyltransferase 1Homo sapiens (human)5.33
NAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)2.5

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Benito, A; Fernández-Luna, JL; Gajate, C; Martín-Martín, B; Martínez-Dalmau, R; Modolell, M; Mollinedo, F1
Hanahan, DJ; Javors, MA; Siafaka-Kapadai, A; Svetlov, S1
Altomare, A; Behar, J; Biancani, P; Harnett, KM; Ma, J; Rieder, F1
Kanai, S; Katakura, F; Kinoshita, R; Koie, H; Nakayama, S; Narita, T; Okabayashi, K; Takeuchi, R; Yamauchi, T1

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and suramin

ArticleYear
Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Cancer research, 1997, Apr-01, Volume: 57, Issue:7

    Topics: Albumins; Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Gene Expression; Genes, bcl-2; Humans; Lymphocytes; Mice; Monocytes; Phospholipid Ethers; Platelet Activating Factor; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Suramin; Tumor Cells, Cultured

1997
Effects of suramin on human platelet aggregation and Ca2+ mobilization induced by thrombin and other agonists.
    Life sciences, 1998, Volume: 63, Issue:20

    Topics: Antineoplastic Agents; Arachidonic Acid; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Drug Antagonism; Humans; Phosphatidic Acids; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Signal Transduction; Suramin; Thrombin

1998
ATP: a mediator for HCl-induced TRPV1 activation in esophageal mucosa.
    American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 301, Issue:6

    Topics: Acetyltransferases; Adenosine Triphosphate; Animals; Antineoplastic Agents; Calcitonin Gene-Related Peptide; Cell Line; Esophagus; Humans; Hydrochloric Acid; Mucous Membrane; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Rabbits; Real-Time Polymerase Chain Reaction; Receptors, Purinergic; Substance P; Suramin; TRPV Cation Channels

2011
Activation of canine neutrophils by platelet-activating factor.
    Veterinary immunology and immunopathology, 2021, Volume: 241

    Topics: Animals; Calcium; Dogs; Neutrophils; Platelet Activating Factor; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Signal Transduction; Suramin

2021